|
Aug 13
|
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk
|
|
Aug 13
|
The 3 Things That Matter for Viking Therapeutics Now
|
|
Aug 13
|
Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry
|
|
Aug 13
|
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration
|
|
Aug 12
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Aug 12
|
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
|
|
Aug 12
|
Sector Update: Health Care Stocks Advance in Afternoon Trading
|
|
Aug 12
|
The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly
|
|
Aug 12
|
Here's Why Novo Nordisk (NVO) is a Strong Growth Stock
|
|
Aug 12
|
3 ways the GLP-1 market has changed shape this year
|
|
Aug 12
|
Novo Nordisk Reduces Sales And Operating Profit Outlook For 2025
|
|
Aug 11
|
WeightWatchers shuns compounded semaglutide amid FDA rules
|
|
Aug 11
|
European Equities Traded in the US as American Depositary Receipts Begin Week Lower in Monday Trading
|
|
Aug 11
|
Can Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval?
|
|
Aug 11
|
Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results?
|
|
Aug 11
|
Novo ramps up lawsuits over Wegovy copies - but not for Hims & Hers
|
|
Aug 11
|
As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?
|
|
Aug 10
|
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade
|
|
Aug 8
|
Why Novo Nordisk Stock Flew Higher on Friday
|
|
Aug 8
|
Microsoft, Palantir Get Analyst Attention
|